case report journal | sciencenewsnet.in

Breaking News

Gene Expression and Bioinformatics Tools to Optimize Cancer Therapy

OrthoInfo.org Offers Osteoporosis Awareness and Prevention Resources for Patients

Cedars-Sinai Physician-Scientist Leads Association of American Physicians

‘Surprising’ hidden activity of semiconductor material spotted by researchers

Coping in the aftermath of a cancer diagnosis

Combined therapy makes headway for liver cancer

Gerald Miles Named to Lead Strategic Development for WCS Global

Network Elites Continues To Grow With Latest Acquisition of Local MSP- 1CallService

Nebraska researcher helps untangle history of fallow deer

‘The Fall Guy’ brings deserved recognition to stunt work, expert shares trade insights

03 May, 2024

Starting CFTR modulator therapy in mother with cystic fibrosis associated with less severe complications in the fetus

June 12, 2023 sarah JonasResearch Alert

A woman with cystic fibrosis was treated with elexacaftor-tezacaftor-ivacaftor (ETI), a cystic fibrosis transmembrane conductance regulator (CFTR) modulator, during pregnancy and gave birth to a healthy baby after experiencing complications in two previous pregnancies. The case report is published in Annals of Internal Medicine.